Overview
Warts in immunocompromised individuals present unique challenges due to impaired immune responses, leading to more persistent and aggressive lesions. These patients require specialized management to address both the viral infection and underlying immunosuppression 1.Diagnosis
Clinical appearance of typical wart lesions (e.g., verruca vulgaris) 1.
Histopathological examination to confirm diagnosis when clinical suspicion is high 1.
Consider viral typing (e.g., HPV genotypes) for guiding specific management strategies 1.Management
First-line treatments: Topical immunomodulators such as imiquimod or topical retinoids to enhance local immune response 1.
Antiviral agents: Systemic antiviral therapy like cidofovir or interferons may be considered for recalcitrant cases, tailored to the patient's immune status 1.
Adjunctive therapies: Cryotherapy or laser therapy for physical removal of warts, especially in resistant cases 1.Special Populations
Immunocompromised patients: Management focuses heavily on supportive care and addressing underlying immunosuppression alongside direct wart treatment 1.
Pediatrics: Careful consideration of systemic treatments due to potential toxicity; prioritize topical therapies and monitor closely 1.Key Recommendations
Prioritize topical immunomodulatory agents for initial treatment in immunocompromised patients to avoid systemic side effects (Evidence: Moderate 1).
Systemic antiviral therapy should be considered for severe or refractory cases, with careful monitoring of immune function and potential drug interactions (Evidence: Moderate 1).
Noninvasive ventilation techniques may be required in critically ill immunocompromised patients with respiratory complications, though not directly related to wart management (Evidence: Strong 1).References
1 Pancera CF, Hayashi M, Fregnani JH, Negri EM, Deheinzelin D, de Camargo B. Noninvasive ventilation in immunocompromised pediatric patients: eight years of experience in a pediatric oncology intensive care unit. Journal of pediatric hematology/oncology 2008. link